ArticleFrontiers in pharmacology2025
Case Report: HGF and NF1 mutations as putative bypass mechanisms of MET inhibitor resistance in hepatocellular carcinoma: a case study.
Zhitao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.